Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

January 1, 2027

Conditions
Mild Cognitive ImpairmentMemory ImpairmentMemory Disorders in Old Age
Interventions
DEVICE

NITESGON

"NITESGON will be delivered by a specially developed, battery-driven, constant current stimulator via a pair of saline-soaked surface sponges on the scalp. One electrode each will be placed over the left and right C2 dermatomes.~NITESGON will first be switched on in a ramp-up fashion over 30 seconds. For active NITESGON, stimulation will occur during the word association task. For sham the current intensity (ramp down) will gradually be reduced (over 5 seconds) as soon as NITESGON reaches a current flow of 1.5 mA. The rationale behind this sham procedure is to mimic the transient skin sensation at the beginning of active NITESGON without producing any conditioning effects on the brain."

DRUG

Lidocaine / Prilocaine Topical Cream

A topical skin anesthetic (lidocaine/prilocaine cream) will be used to reduce any potential contribution from transcutaneous stimulation of peripheral nerves. This lidocaine/prilocaine preparation blocks sodium channels in peripheral nerves in the skin and thereby stabilizes the membrane potential and increases the threshold for firing an action potential.

DEVICE

C5/C6 stimulation

The electrodes will be placed over cervical nerves five and six, to mimic the sensation, but change the location.

DEVICE

Sham NITESGON

Sham NITESGON

Trial Locations (1)

Dublin 2

RECRUITING

TCIN, Dublin

All Listed Sponsors
collaborator

Alzheimer's Association

OTHER

lead

University of Dublin, Trinity College

OTHER